🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Chongqing Medical University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Chongqing Medical University as lead sponsor. Synced 26 Sep 2026
10Current trials
9Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Chongqing Medical University is the lead sponsor of 10 current clinical trials in our China register. 9 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Primary Aldosteronism.

ClinicalTrials.gov trials by status

  • Recruiting990%
  • Not yet open110%

Trials by phase

  • Not applicable660%
  • Observational440%
01

Clinical trials sponsored by Chongqing Medical University

10 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Physiological Study of High PEEP in Noninvasive Ventilation
NCT07503509 · Respiratory Failure With Hypoxia
Not applicable Recruiting 2024-03 China
Chongqing Primary Aldosteronism Study
NCT03224312 · ClinicalTrials.gov ↗ · Primary Aldosteronism
Observational Recruiting 2016-10 China
Shortwave Intervention for Diabetic Peripheral Neuropathy.
NCT07625007 · ClinicalTrials.gov ↗ · Diabetic Peripheral Neuropathy
Not applicable Recruiting 2026-05 China
Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism
NCT07673445 · ClinicalTrials.gov ↗ · Primary Aldosteronism
Not applicable Recruiting 2026-07 China
Prediction of Extubation Failure: A Multicenter Prospective Observational Study
NCT05069441 · ClinicalTrials.gov ↗ · Mechanical Ventilation
Observational Recruiting 2021-10 China
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
NCT05974904 · ClinicalTrials.gov ↗ · Metabolic Dysfunction-associated Fatty Liver Disease, Hepatic Steatosis, Liver Fibrosis
Observational Recruiting 2023-07 China
Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy
NCT07625020 · ClinicalTrials.gov ↗ · Diabetic Peripheral Neuropathy, Entrapment Neuropathy
Not applicable Recruiting 2026-05 China
High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS
NCT07298889 · ClinicalTrials.gov ↗ · Noninvasive Ventilation, Pneumonia, ARDS
Not applicable Recruiting 2026-01 China
Chongqing Diabetes Registry Study
NCT03692884 · ClinicalTrials.gov ↗ · Diabetes Mellitus
Observational Recruiting 2018-07 China
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
NCT07700472 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Aldosterone-Producing Adenoma
Not applicable Not yet open 2026-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Chongqing Medical University trials

13 conditions
Primary Aldosteronism3Diabetic Peripheral Neuropathy2Respiratory Failure With Hypoxia1Mechanical Ventilation1Metabolic Dysfunction-associated Fatty Liver Disease1Hepatic Steatosis1Liver Fibrosis1Entrapment Neuropathy1Aldosterone-Producing Adenoma1Noninvasive Ventilation1Pneumonia1ARDS1Diabetes Mellitus1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China109

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Primary Aldosteronism

SponsorTrials
Qifu Li5
Xinjiang Medical University4
Third Military Medical University2

Sponsors with the most current trials registered for this condition.

05

Questions about Chongqing Medical University trials

How many clinical trials does Chongqing Medical University sponsor?

Chongqing Medical University is the lead sponsor of 10 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Chongqing Medical University trials recruiting?

Yes. 9 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.